Advanced Solid Tumors
Advanced solid tumors are cancers that have progressed beyond the initial stage, forming solid masses in organs or tissues, and may spread to other parts of the body.
Repotrectinib for Advanced Cancers in Kids and Young Adults
We are studying a new treatment for children and young adults with advanced cancers that have specific genetic changes. The trial aims to evaluate how well it works and its safety.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 12 and 25 years old?
- Do you have a confirmed NTRK+ advanced solid tumor or ROS1 gene fusion?
- Are you currently pregnant or breastfeeding?
- Have you had major surgery in the past 14 days?
- Have you had any active infections that require ongoing treatment?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Rigshospitalet
Afdeling for Børn og Unge
Copenhagen, Denmark
Centre Hospitalier Universitaire D'Angers
Paediatric immuno-haemato-oncology
Angers, France
Pellegrin Hospital
pediatric hematology and cancer
Bordeaux, France
Sponsor: Turning Point Therapeutics Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.